ALEXION PHARMACEUTICALS, INC. (ALXN) has 466 open-market insider trades by 44 insiders since 2006. The most active filer is David Hallal, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| BAKER Bros. Advisors L.P. via Julian Baker | Dir | — | 4 | $336.6M | 2019-05-30 |
| Baker Brothers Life Sciences LP | Dir | — | 2 | $311.0M | 2018-05-09 |
| Baker Bros. Advisors (GP) LLC via Felix Baker | Dir | — | 2 | $78.8M | 2020-03-18 |
| Felix Baker | Dir | — | 4 | $73.7M | 2020-05-14 |
| Thomas I. H. Dubin | CLO | — | 34 | $57.3M | 2012-08-23 |
| Leonard Bell | Dir | — | 49 | $46.9M | 2017-03-01 |
| Patrice Coissac | SVP & Pres. ALXN Pharma Int'l | — | 7 | $36.5M | 2012-10-31 |
| Stephen P. Squinto | EVPChief Global Ops. Officer | — | 41 | $33.8M | 2014-10-27 |
| David Hallal | CEO | — | 50 | $32.6M | 2016-08-08 |
| Max Link | Dir | — | 6 | $27.5M | 2014-02-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Daniel Bazarko | CAO & VP +1 | Sell | $5.9M | 2020-12-17 |
| Tanisha Carino | VP | Sell | $374K | 2020-12-03 |
| Indrani Lall Franchini | CCO & VP | Sell | $1.4M | 2020-06-08 |
| Baker Bros. Advisors (GP) LLC | Director | Buy | $13.3M | 2020-03-18 |
| Baker Bros. Advisors (GP) LLC | Director | Buy | $65.5M | 2020-03-16 |
| Indrani Lall Franchini | CCO & VP | Sell | $598K |
Companies that share insiders with ALXN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-07-01 |
| Aradhana Sarin | — | Sell | $76K | 2019-06-21 |
| Felix Baker | Director | Sell | $6.9M | 2019-05-30 |
| Felix Baker | Director | Sell | $14.5M | 2019-05-29 |
| Felix Baker | Director | Sell | $36.6M | 2019-05-28 |
| BAKER Bros. Advisors L.P. | Director | Sell | $37.1M | 2019-05-28 |
| Felix Baker | Director | Sell | $15.6M | 2019-05-28 |
| Daniel Bazarko | CAO & VP +1 | Sell | $252K | 2019-02-14 |
| Ludwig Hantson | CEO | Sell | $622K | 2018-12-31 |
| Indrani Lall Franchini | CCO & VP | Sell | $615K | 2018-11-28 |